Status: Recruiting
Proteogenomic Monitoring and Assessment of Liver Transplant Recipients
This study is being done to test blood, urine and tissue samples to see if this can help decide if CKD (Chronic Kidney Disease), AR (Acute Rejection) and HCV (Hepatitis C Virus) can be identified in its early stages. CKD damage to the kidneys, AR and HCV all lower the body's ability to function properly. Early detection of these conditions could assist with successful treatment and possibly lead to less repeat organ transplants.
Participants needed: 1,000
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Northwestern UniversityUpdated: May 22, 2026Locations: 1
Eligibility criteria
Male and female recipients of all races, ≥18 years of age. [+3]